Regulation of inflammation and redox signaling by dietary polyphenols

Bravo, 1998, Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance, Nutr Rev, 56, 317, 10.1111/j.1753-4887.1998.tb01670.x Eastwood, 1999, Interaction of dietary antioxidants in vivo: how fruit and vegetables prevent disease?, Q J Med, 92, 527, 10.1093/qjmed/92.9.527 Harborne, 1980, Plant phenolics, vol. 8, 329 Siemann, 1992, Concentration of the phytoalexin resveratrol in wine, Am J Enol Vitic, 43, 49, 10.5344/ajev.1992.43.1.49 Trela, 1996, Resveratrol: isomeric molar absorptivities and stability, J Agric Food Chem, 44, 1253, 10.1021/jf9504576 Aggarwal, 2004, Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies, Anticancer Res, 24, 2783 Beecher, 2003, Overview of dietary flavonoids: nomenclature, occurrence and intake, J Nutr, 133, 3248S, 10.1093/jn/133.10.3248S Andlauer, 2000, Assessment of resveratrol bioavailability in the perfused small intestine of the rat, Drugs Exp Clin Res, 26, 47 Vitrac, 2003, Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration, Life Sci, 72, 2219, 10.1016/S0024-3205(03)00096-1 Yu, 2002, Human, rat, and mouse metabolism of resveratrol, Pharm Res, 19, 1907, 10.1023/A:1021414129280 Wahlstrom, 1978, A study on the fate of curcumin in the rat, Acta Pharmacol Toxicol, 43, 86, 10.1111/j.1600-0773.1978.tb02240.x Ireson, 2001, Characterization of metabolites of the chemopreventive agent curcumin in humans and rat hepatocytes and in rat plasma and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production, Cancer Res, 61, 1058 Ravindranath, 1981, In vitro studies on the intestinal absorption of curcumin in rats, Toxicology, 20, 251, 10.1016/0300-483X(81)90056-1 Wang, 1997, Stability of curcumin in buffer solution and characterization of its degradation products, J Pharm Biomed Anal, 15, 1867, 10.1016/S0731-7085(96)02024-9 Chen, 1997, Absorption, distribution, and elimination of tea polyphenols in rats, Drug Metab Dispos, 25, 1045 Das, 1969, Studies on flavonoid metabolism. Metabolism of (+)-[14C] catechin in the rat and guinea pig, Biochem J, 115, 831, 10.1042/bj1150831 Williams, 2004, Flavonoids: antioxidants or signalling molecules?, Free Radic Biol Med, 36, 838, 10.1016/j.freeradbiomed.2004.01.001 Cheng, 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer Res, 21, 2895 Shoba, 1998, Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers, Planta Med, 64, 353, 10.1055/s-2006-957450 van Amelsvoort, 2001, Plasma concentrations of individual tea catechins after a single oral dose in humans, Xenobiotica, 31, 891, 10.1080/00498250110079149 Meng, 2002, Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats, Chem Res Toxicol, 15, 1042, 10.1021/tx010184a Natsume, 2003, Structures of (−)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (−)-epicatechin: differences between human and rat, Free Radic Biol Med, 34, 840, 10.1016/S0891-5849(02)01434-X Sharma, 1976, Antioxidant activity of curcumin and related compounds, Biochem Pharmacol, 25, 1811, 10.1016/0006-2952(76)90421-4 Joe, 1994, Role of capsaicin, curcumin and dietary n−3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages, Biochim Biophys Acta, 1224, 255, 10.1016/0167-4889(94)90198-8 Mahakunakorn, 2003, Cytoprotective and cytotoxic effects of curcumin: dual action on H2O2 induced oxidative cell damage in NG108-15 cells, Biol Pharm Bull, 26, 725, 10.1248/bpb.26.725 Reddy, 1992, Studies on spice principles as antioxidant in the inhibition of lipid peroxidation of rat liver microsomes, Mol Cell Biochem, 111, 117 Starsser, 2005, The relationship between the anti-inflammatory effects of curcumin and cellular glutathione content in myelomonocytic cells, Biochem Pharmacol, 70, 552, 10.1016/j.bcp.2005.05.030 Kelly, 2001, Disparate effects of similar phenolic phytochemicals as inhibitors of oxidative damage to cellular DNA, Mutat Res, 485, 309, 10.1016/S0921-8777(01)00066-0 Galati, 2002, Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics, Toxicology, 177, 91, 10.1016/S0300-483X(02)00198-1 Sreejayan Rao, 1994, Curcuminoids as potent inhibitors of lipid peroxidation, J Pharm Pharmacol, 46, 1013, 10.1111/j.2042-7158.1994.tb03258.x Heijnen, 2001, Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups, Toxicol In Vitro, 15, 3, 10.1016/S0887-2333(00)00053-9 Rice-Evans, 1999, Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans, Proc Natl Acad Sci USA, 220, 262 Yoshida, 1999, Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein, Biochem Pharmacol, 58, 1695, 10.1016/S0006-2952(99)00256-7 Higdon, 2003, Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions, Crit Rev Food Sci Nutr, 43, 89, 10.1080/10408690390826464 Wang, 1996, Tea and cancer prevention, 239 Hong, 2002, Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (−)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells, Cancer Res, 62, 7241 Sherwood, 2004 Miller, 1995, Antioxidant activity of resveratrol in red wine, Clin Chem, 41, 1789, 10.1093/clinchem/41.12.1789 Frankel, 1993, Inhibition of human LDL oxidation by resveratrol, Lancet, 341, 1103, 10.1016/0140-6736(93)92472-6 Wilson, 1996, Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits, Life Sci, 59, L15, 10.1016/0024-3205(96)00260-3 Hattori, 2002, Pharmacological preconditioning with resveratrol: role of nitric oxide, Am J Physiol, 282, H1988 Olas, 2001, The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin, Microbios, 105, 7 Aggarwal, 2004, Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning, Ann NY Acad Sci, 1030, 434, 10.1196/annals.1329.054 Birrell, 2005, Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism, FASEB J, 19, 840, 10.1096/fj.04-2691fje Manna, 2000, Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappaB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation, J Immunol, 164, 6509, 10.4049/jimmunol.164.12.6509 Donnelly, 2004, Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms, Am J Physiol Lung Cell Mol Physiol, 287, L774, 10.1152/ajplung.00110.2004 Von Knethen, 1999, Superoxide attenuates macrophage apoptosis by NF-κB and AP-1 activation that promotes cyclooxygenase-2 expression, J Immunol, 163, 2858, 10.4049/jimmunol.163.5.2858 Clement, 1998, Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells, Blood, 92, 996, 10.1182/blood.V92.3.996 Leiro, 2005, Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling, Int Immunopharmacol, 5, 393, 10.1016/j.intimp.2004.10.006 Ashikawa, 2002, Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation, J Immunol, 169, 6490, 10.4049/jimmunol.169.11.6490 Miloso, 1999, Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SHSY5Y cells, Neurosci Lett, 264, 141, 10.1016/S0304-3940(99)00194-9 Shih, 2002, Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism, J Clin Endocrinol Metab, 87, 1223, 10.1210/jcem.87.3.8345 El-Mowafy, 1999, Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects, FEBS Lett, 451, 63, 10.1016/S0014-5793(99)00541-4 She, 2002, Involvement of -jun NH92-terminal kinases in resveratrol-induced activation of p53 and apoptosis, Mol Carcinog, 33, 244, 10.1002/mc.10041 Das, 2006, Potentiation of a survival signal in the ischemic heart by resveratrol through p38mapk msk-1-creb signaling, J Pharmacol Exp Ther, 317, 980, 10.1124/jpet.105.095133 Das, 2005, Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and -independent pathways, J Pharmacol Exp Ther, 314, 762, 10.1124/jpet.105.084285 Biswas, 2005, Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity, Antioxid Redox Signal, 7, 32, 10.1089/ars.2005.7.32 Shishodia, 2003, Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and Cyclin D1, Carcinogenesis, 24, 1269, 10.1093/carcin/bgg078 Jobin, 1999, Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappaB kinase activity, J Immunol, 163, 3474, 10.4049/jimmunol.163.6.3474 Nanji, 2003, Curcumin prevents alcoholinduced liver disease in rats by inhibiting the expression of NF-kappaB-dependent genes, Am J Physiol Gastrointest Liver Physiol, 284, G321, 10.1152/ajpgi.00230.2002 Plummer, 1999, Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex, Oncogene, 18, 6013, 10.1038/sj.onc.1202980 Duvoix, 2005, Chemopreventive and therapeutic effects of curcumin, Cancer Lett, 223, 181, 10.1016/j.canlet.2004.09.041 Deeb, 2003, Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells, Mol Cancer Ther, 2, 95 Adhami, 2003, Molecular targets for green tea in prostate cancer prevention, J Nutr, 133, 2417S, 10.1093/jn/133.7.2417S Ahmad, 2000, Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells, Arch Biochem Biophys, 376, 338, 10.1006/abbi.2000.1742 Lin, 1999, Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade, Biochem Pharmacol, 58, 911, 10.1016/S0006-2952(99)00112-4 Vittal, 2004, Gene expression changes induced by green tea polyphenol (−)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray, Mol Cancer Ther, 3, 1091, 10.1158/1535-7163.1091.3.9 Yamamoto, 2004, Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects, Pharmacol Exp Ther, 308, 317, 10.1124/jpet.103.058891 Dong, 1997, Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (−)-epigallocatechin gallate, and theaflavins, Cancer Res, 57, 4414 Nomura, 2000, Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (−)-epigallocatechin gallate and theaflavins, Carcinogenesis, 21, 1885, 10.1093/carcin/21.10.1885 Fassina, 2004, Albini. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate, Clin Cancer Res, 10, 4865, 10.1158/1078-0432.CCR-03-0672 Wheeler, 2004, Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells, J Nutr, 134, 1039, 10.1093/jn/134.5.1039 Kawai, 2004, Epigallocatechin gallate attenuates adhesion and migration of CD8+ T cells by binding to CD11b, J Allergy Clin Immunol, 113, 1211, 10.1016/j.jaci.2004.02.044 Yu, 1997, Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression, Carcinogenesis, 18, 451, 10.1093/carcin/18.2.451 Chen, 2000, Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death, Arch Pharm Res, 23, 605, 10.1007/BF02975249 Dinkova-Kostova, 2002, Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants, Proc Natl Acad Sci USA, 99, 11908, 10.1073/pnas.172398899 Lee, 2005, Nrf2 as a novel molecular target for chemoprevention, Cancer Lett, 224, 171, 10.1016/j.canlet.2004.09.042 Balogun, 2003, Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element, Biochem J, 371, 887, 10.1042/bj20021619 Yang, 2005, Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1, Mol Cell Biol, 25, 5933, 10.1128/MCB.25.14.5933-5946.2005 Chen, 2005, Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells, Biochem Biophys Res Commun, 331, 993, 10.1016/j.bbrc.2005.03.237 Barnes, 2000, Inhaled corticosteroids are not helpful in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 161, 342, 10.1164/ajrccm.161.2.16125_2 Barnes, 2006, Corticosteroid effects on cell signalling, Eur Respir J, 27, 413, 10.1183/09031936.06.00125404 Kirkham, 2006, Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy, Pharm Ther, 111, 476, 10.1016/j.pharmthera.2005.10.015 Ito, 2001, Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages, FASEB J, 15, 1110, 10.1096/fj.00-0432fje Rahman, 2004, Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression, Biochem Pharmacol, 68, 1255, 10.1016/j.bcp.2004.05.042 Rahman, 2002, Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation, Mol Cell Biochem, 234–235, 239, 10.1023/A:1015905010086 Ito, 2002, A molecular mechanism of action of theophyline: induction of HDAC activity to decrease inflammatory gene expression, Proc Natl Acad Sci, 99, 8921, 10.1073/pnas.132556899 Culpitt, 2003, Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD, Thorax, 58, 942, 10.1136/thorax.58.11.942 Ito, 2005, Decreased histone deacetylase activity in chronic obstructive pulmonary disease, N Engl J Med, 352, 1967, 10.1056/NEJMoa041892 Rahman, 2005, Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms, Cell Biochem Biophys, 43, 167, 10.1385/CBB:43:1:167 Yang, 2006, Cigarette smoke induces pro-inflammatory cytokine release by activation of nf-{kappa}b and post-translational modifications of histone deacetylase in macrophages, Am J Physiol Lung Cell Mol Physiol, 29, L46, 10.1152/ajplung.00241.2005 Kang, 2005, Curcumin-induced histone hypoacetylation: the role of reactive oxygen species, Biochem Pharmacol, 69, 1205, 10.1016/j.bcp.2005.01.014 Knekt, 2002, Flavonoid intake and risk of chronic diseases, Am J Clin Nutr, 76, 560, 10.1093/ajcn/76.3.560 Tabak, 2001, Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN study, Am J Respir Crit Care Med, 164, 61, 10.1164/ajrccm.164.1.2010025 Walda, 2002, Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countries, Eur J Clin Nutr, 56, 638, 10.1038/sj.ejcn.1601370 Santus, 2005, Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 171, 838, 10.1164/rccm.200404-558OC Morel, 1998, Flavonoid-metal interactions in biological systems, 163 Lotito, 2000, Ascorbate protects (+)-catechin from oxidation both in pure chemical system and human plasma, Biol Res, 33, 151, 10.4067/S0716-97602000000200015